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Abstract
Background: Experimental models of pulmonary embolism (PE) that produce pulmonary hypertension (PH)
employ many different methods of inducing acute pulmonary occlusion. Many of these models induce PE with
intravenous injection of exogenous impervious objects that may not completely reproduce the physiological
properties of autologous thromboembolism. Current literature lacks a simple, well-described rat model of autlogous
PE. Objective: Test if moderate-severity autologous PE in Sprague-Dawley (SD) and Copenhagen (Cop) rats can
produce persistent PH.
Methods: blood was withdrawn from the jugular vein, treated with thrombin-Ca
++ and re-injected following
pretreatment with tranexamic acid. Hemodynamic values, clot weights and biochemical measurements were
performed at 1 and 5 days.
Results: Infusion of clot significantly increased the right ventricular peak systolic pressure to 45-55 mm Hg,
followed by normalization within 24 hours in SD rats, and within 5 days in COP rats. Clot lysis was 95% (24 hours)
and 97% (5 days) in SD rats and was significantly lower in COP rats (70%, 24 hours; 87% 5 days). Plasma D-dimer
was elevated in surgical sham animals and was further increased 8 hours after pulmonary embolism. Neither strain
showed a significant increase in bronchoalveolar chemotactic activity, myeloperoxidase activity, leukocyte
infiltration, or chemokine accumulation, indicating that there was no significant pulmonary inflammation.
Conclusions: Both SD and COP rats exhibited near complete fibrinolysis of autologous clot PE within 5 days.
Neither strain developed persistent PH. Experimental models of PE designed to induce sustained PH and a robust
inflammatory response appear to require significant, persistent pulmonary vascular occlusion.
Background
Several laboratory models have been developed and
implemented to study experimental pulmonary embo-
lism (PE) in the rat. In the broadest terms, these models
can be categorized into two groups: injected thrombus
versus foreign body. The thrombus models utilize a
blood sample obtained from the same (autologous) or a
donor (heterologous) animal that is coagulated ex-vivo
to produce an organized thrombus which is then (re)
injected into the experimental animals [1]. The foreign
body models infuse inert objects, such as polystyrene,
sephadex or glass microspheres, into the venous circula-
tion to create a fixed pulmonary vascular obstruction
[2-4]. Each method offers advantages and limitations.
The injected clot model provides a closer representation
of acute pulmonary thromboembolism, but the percen-
tage and persistence of the resultant pulmonary vascular
occlusion can be difficult to control because of the irre-
gular size and volume of ex-vivo clots, and the effect of
the rat’s high rate of fibrinolysis. The physiologic effects
of hemolysis associated with clot formation and injec-
tion represent another potential confounding variable in
such models. Additionally, although blood for thrombus
can be donated from a highly genetically similar * Correspondence: jwatts@carolinas.org
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any medium, provided the original work is properly cited.littermate, this does not exclude the possibility of a mild
immunological reaction. Existing autologous models of
PE require a two-stage laparatomy[5], or produce pro-
found circulatory shock in rats[1], rabbits[6] or pigs[7]
On the other hand, foreign body models can be more
carefully titrated to control the severity of PE, but it is
self-evident that plastic or glass beads incompletely
reproduce the pathophysiologic manifestations of acute
pulmonary thromboembolism.
We sought to develop a less invasive rat model of
moderately severe autologous-clot PE. Many of the pre-
viously cited models utilize Sprague-Dawley rats, a strain
shown to demonstrate high rates of endogenous fibrino-
lytic activity [8]. However, work by Cooley, et al, has
revealed a potentially profound prothrombotic tendency
in Copenhagen rats [9]. Therefore, we performed our
experiments in both Sprague-Dawley and Copenhagen
rats and compared the effects of our model among the
two strains.
Materials and methods
All experiments were conducted in accordance with the
National Institutes of Health guidelines on the use of
experimental animals. The study protocol was approved
by the Carolinas Medical Center Institutional Animal
Care and Use Committee and all experiments were con-
ducted in accordance with the Guide for the Care and
Use of Laboratory Animals. Animals were housed in an
Association for Assessment and Accreditation of
Laboratory Animal Care-approved level III vivarium and
allowed ad libitum access to food and water prior to all
procedures and after recovery from anesthesia. Studies
were conducted in male Sprague-Dawley and Copenha-
gen rats weighing 366-429 grams and 220-266 grams,
respectively.
Following anesthesia with an intraperitoneal injection
of a mixture of xylazine (3 mg/kg) and ketamine (70
mg/kg), the animals were weighed, a baseline tempera-
ture measurement taken, and they were placed on a
warming pad filled with re-circulating water warmed to
105°F (Gaymar solid-state T-pump; Orchard Park, NY).
The neck was shaved and the skin prepped aseptically.
The right jugular vein was dissected and cannulated
with a 2-Fr Millar Mikro-Tip catheter transducer (Millar
Instruments, Houston, TX). The Millar transducers were
connected to a Transducer Balance Box, a UM 100A
coupling box and an MP100 data acquisition unit,
which was connected to a personal computer. Pressures
were recorded using Acknowledge software (BIOPAC
Systems, Goleta, CA). The transducer was advanced into
the right ventricle for baseline pressure measurement.
The transducer was removed and the vein cannulated
with PE-50 tubing and 0.5 mL blood withdrawn into a
heparinized syringe for D-dimer measurement (initial D-
dimer, -24 hr). PE-200 (Sprague-Dawley) or PE-160
(Copenhagen) tubing was then inserted into the right
external jugular vein and blood withdrawn to fill the
length of the tubing and just into the barrel of a 12 mL
syringe that was been pre-filled with 100 μL calcium
chloride (100 mM) and 100 μL thrombin (10 units/mL)
to enhance clot formation. The length of the tubing,
and the resultant volume of clot, were weight-based and
took into account the relative smaller size of the Copen-
hagen animals. Pilot data determined the optimal total
clot dose to reliably result in acute pulmonary hyperten-
sion, defined as a right ventricular pressure of greater
than 40 mmHg, to be 22 mg per 100 grams body weight
for the Sprague-Dawley animals and significantly less,
2.8 mg per 100 grams body weight, for the Copenhagen
animals. The catheter was removed from the animal and
t h eb l o o dd r a w nc o m p l e t e l yi n t ot h es y r i n g ea n da g i -
tated to facilitate mixing with the calcium and thrombin
before being injected back into the tubing with care
taken to avoid air bubbles. The clot was incubated in
the tubing at 37°C for 3 hours and then placed at 4°C
for 21 hours. Blood loss was replaced with a volume of
0.9% sodium chloride equal to two and one half times
that of the blood removed. The skin incision was closed
with a surgical clip and the animal was allowed to
recover from anesthesia.
At 24 hours, the clot-containing tubing was retrieved
and the distal end disinfected with 2% chlorhexidine dia-
cetate and rinsed with sterile water. The animals were
anesthetized and prepped as above, the wound clip
removed, and the incision opened. The right jugular
vein was re-cannulated, the right ventricular pressure
measured, and 0.5 mL of blood was drawn into a hepar-
inized syringe for D-dimer measurement (0 hr) (Assera-
chrom D-Dimer kit, Diagnostica, Stago, Parsippany, NJ).
To attenuate the animal’s endogenous fibrinolytic activ-
ity, tranexamic acid was injected (60 mg/100 gm) intra-
venously prior to clot injection. Tranexamic acid has
been shown to increase the persistence of embolic clot
material in rats [10]. The distal one cm of the clot-con-
taining tubing was amputated and discarded, the newly
cut end of the tubing was inserted into the right jugular
vein, and the clot was segmented by crimping the tubing
with hemostats at 1 cm intervals (Figures 1 &2). To
minimize mortality during clot injection, the initial clot
bolus (18 mg/100 grams body weight for Sprague-Daw-
ley and 5 mg for Copenhagen animals) was infused
slowly over five minutes. The tubing was then removed
and the right ventricular pressure measured. If the right
ventricular pressure was less than 40 mmHg, a supple-
mental clot dose (4 mg/100 grams body weight for Spra-
gue-Dawley and up to 5 mg for Copenhagen animals)
was infused over five minutes. If the right ventricular
pressure remained less than 40 mmHg after the
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from the study and euthanized with an intraperitoneal
injection of 260 mg/kg of 26% sodium pentobarbital.
Animals meeting the targeted right ventricular pressure
had an indwelling tunneled catheter placed in the jugu-
lar vein to facilitate interval blood draws for D-dimer
measurement at 8 hours and 24 hours after clot injec-
tion. The animals were then returned to their cages and
allowed to recover. The sham procedure was the same
as above, except that the clotted blood was discarded
and 0.9% NaCl was infused into the animal instead of
the clot.
At the end of the experiment (24 hours or 5 days), the
animals were anesthetized and prepped as above. The
carotid artery was dissected and a 2-Fr Millar Mikro-
Tip catheter transducer inserted to measure arterial
pressure. The right ventricular pressure was measured
as previously described.
Figure 1 Tubing with segmented, “hardened” clot material just before injection into the jugular vein of a rat.
Figure 2 Segmented “hardened” clot material retrieved from the pulmonary artery immediately after injection into the jugular vein of
a rat, illustrating the embolization of injected clot into the lung vasculature.
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wash and bronchoalveolar lavage (BAL) performed as
previously described [11]. The recovered fluid was cen-
trifuged and the supernatant was stored at -70°F. The
cell pellets were subjected to hypotonic cell lysis to
eliminate erythrocytes and leukocyte infiltration quanti-
fied on a hemocytometer. After centrifugation, the cell
pellets were stored at -70°F until needed for additional
measurements. The heart and lungs were removed and
the pulmonary arteries dissected to retrieve any clot.
Recovered clot was weighed (wet weight) and then dried
for 24 hours at 37°C and re-weighed (dry weight). Clot
lysis was estimated by subtracting the dry weight of the
recovered clot from the estimated dry weight of the
total injected clot dose.
Chemotactic activity
Neutrophils were purified using Polymorphprep™ cell
separation medium (Accurate Chemical and Scientific,
Westbury, NY) and chemotaxis assays performed using
24-well Corning-Costar Transwell® migration chambers
as previously described [11]. Formaldehyde/EDTA-fixed
cells were collected by centrifugation (5 min at 450 × g)
and counted with a hemocytometer.
Myeloperoxidase activity
Myeloperoxidase (MPO) activity was measured in BAL
cell pellets that were suspended in lysis buffer (100 mM
potassium phosphate [pH 6.0], 5 mM EDTA, and 0.5%
hexadecyltrimethylammonium bromide). The assay was
performed in 96-well microtiter plates by adding sub-
strate buffer containing 0.01% o-dianisidine-HCl and
0.01% hydrogen peroxide. Plates were incubated at
room temperature for one hour and read at 450 nm in a
UV Max microplate reader (Molecular Devices, Sunny-
vale, CA). Protein was quantified in each MPO extract
using the biconchoninic acid (BCA) method and MPO
activity was normalized to protein concentration. MPO
standard curves were constructed using purified human
myeloperoxidase (Sigma-Aldrich catalog no. M6908).
Chemokine measurements
Chemokine protein content was determined in the BAL
supernatant utilizing the following assays: Monocyte
chemoattractant protein (MCP-1) (OptEIA set #555130
and reagent A set #55053, Pharmingen, San Diego, CA);
Cytokine-induced neutrophil chemoattractant, CINC-1
and CINC-2 (DuoSet kits #DY515 and # DY516, R&D
Systems, Minneapolis, MN); CINC-3 (Macrophage-
inflammatory protein-2, created using mouse monoclo-
nal anti-CINC3 primary mAb #MAB525, biotinylated
goat anti-CINC3 secondary IgG R&D #BAF525 and
recombinant rat CINC3 standard #525-C3, R&D Sys-
tems, Minneapolis, MN).
Statistics
Data are shown as means ± standard error of the mean.
Continuous data were tested for normality using the
Wilk-Shapiro statistic (P > 0.1). Hemodynamic variables
that were measured more than once in the same ani-
mals were compared using repeat measures ANOVA
(RM ANOVA) followed by t-tests. Clot content, mea-
sured at the time of dosing and at the end of the experi-
ment was tested by paired t-test and independent
continuous variables were compared between groups
with an unpaired t-test with P < 0.05 considered signifi-
cant. We used a Bonferroni-adjusted P value to correct
for multiple measurements.
Results
The experimental animals consisted of 58 total animals,
40 Sprague-Dawley and 18 Copenhagen rats. We allo-
cated 10 Sprague-Dawley animals to each of 4 groups:
24-hour PE, 24-hour sham, 5-day PE, and 5-day sham.
We planned for 5 Copenhagen animals each in the
same 4 groups, but there was one death in each of the
PE groups, leaving 4 animals each of the 2 PE groups
and 5 in each of the sham groups. Among each strain,
the animals were similar weights, but between strains,
the Copenhagen animals were significantly smaller
(Table 1). This difference was expected given their
respective normal growth curves.
Sprague-Dawley Results
The total clot dose for the Sprague-Dawley animals was
18.4 ± 0.1 mg/100 grams and 18.5 ± 0.1 mg/100 grams
for the 24-hour and 5-day groups respectively (Figure 3).
At the end of the experiments, a measurable amount of
residual clot was retrieved from the pulmonary arteries
of all the PE animals, save one in the 5-day group. Over-
all clot lysis was 95 ± 1.0% at 24 hours and 97 ± 0.8% at 5
days. There was no clot recovered from the pulmonary
arteries of any of the sham animals. Plasma D-dimer
values were increased significantly more 8 hours after
injection of clot material compared with sham surgery
and returned to sham levels by 24 hours after injection of
clot material in the Sprague-Dawley PE group (Figure 4).
Baseline right ventricular pressures, measured before
treatment, were not significantly different (p > 0.05 all
comparisons) in any of the experimental groups (Figure
3). Peak right ventricular pressure increased significantly
following clot injection (55.0 ± 2.1 mmHg clot versus
33.2 ± 0.8 baseline, 24 hr experiment; 57.0 ± 1.6 clot
versus 30.6 ± 0.9 baseline, 5 day experiment), while ani-
mals receiving sham injection showed no significant
change in peak right ventricular pressure in either
experiment. Right ventricular pressures returned to
values not significantly different from baseline 24 hours
or 5 days after induction of PE (Figure 3). Due to
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cing catheter, right ventricular pressure measurements
were unobtainable in one animal in the 24-hour PE
group and in 3 each in the 5-day PE and 5-day sham
groups.
Several indices of inflammation were examined in the
Sprague-Dawley rat lungs (Table 1). Chemotactic activ-
ity of the BAL supernatant was not different between
sham and PE animals in either the 24 hour or 5 day
experiment. Examination of the BAL cell pellet demon-
strated no significant difference in myeloperoxidase
activity among the 4 groups. BAL pellet cell counting
revealed 543 ± 45.1 × 10
3 and 337 ± 35.4 × 10
3 leuko-
cytes in the 24-hour PE and sham (p = 0.002), and 587
±8 2 . 4×1 0
3 and 514 ± 39.5 × 10
3 leukocytes in the 5-
day PE and sham animals. Measured levels of the che-
mokines MCP-1, CINC-1, CINC-2, and CINC-3 are
shown in Table 1 and were not significantly different in
the PE versus sham animals at either time point.
Copenhagen Results
The total clot dose for the Copenhagen animals was 3.0
± 0.5 mg/100 grams and 2.4 ± 0.2 mg/100 grams for the
24-hour and 5-day groups respectively (Figure 3). At the
end of the experiments, residual clot was retrieved from
the pulmonary arteries of all the experimental animals,
except for two in the 5-day group. Overall clot lysis was
69.8 ± 7.4% at 24 hours (p < 0.001 compared to the 24-
hour Sprague-Dawley PE animals) and 87.3 ± 7.6% at 5
days (p < 0.052 compared to the 5-day Sprague-Dawley
PE animals). There was no clot recovered from the pul-
monary arteries of any of the sham animals.
Baseline right ventricular pressure, measured before
treatment, were not significantly different (p > 0.05 all
comparisons) in any of the experimental groups (Figure
3). Peak right ventricular pressure increased significantly
following clot injection (44.9 ± 1.5 mmHg clot versus
27.0 ± 0.9 baseline in the 24-hour experiment, and 44.7
± 1.5 clot versus 31.8 ± 1.8 baseline in the 5-day experi-
ment, while animals receiving sham injection showed no
significant change in right ventricular pressure in either
experiment. The right ventricular pressure partially
returned to baseline (32.0 ± 1.0 mmHg PE 24 hr versus
27.0 ± 0.9 mmHg baseline, p < 0.007) at the end of the
24-hour experiment and was not significantly different
from baseline at 5 days. Due to technical difficulty with
inserting the pressure transducer, right ventricular pres-
sure measurements were unobtainable in one animal in
the 24-hour PE group and in 2 in the 5-day sham group.
Inflammatory indices measured in the Copenhagen
animals are shown in Table 1. Chemotactic activity of
the BAL supernatant was not different between sham
and PE animals in either the 24 hour or 5 day experi-
ment. Examination of the BAL cell pellet demonstrated
no difference in myeloperoxidase activity among the 4
groups. BAL pellet cell counting revealed 491 ± 25.6 ×
Table 1 Lung inflammation measurements
Parameter Time Sprague-Dawley Copenhagen
PE Sham Sig. PE Sham Sig
Weight (g) 24 hr 399 ± 5 392 ± 4 n.s. 240 ± 8 254 ± 2 n.s.
5 day 402 ± 5 393 ± 5 n.s. 244 ± 8 245 ± 4 n.s.
Pleural WBC (×10
5) 24 hr 108 ± 19 109 ± 32 n.s. 27 ± 4 32 ± 4 n.s.
5 day 107 ± 16 109 ± 4 n.s. 39 ± 8 31 ± 3 n.s.
BAL WBC (×10
3) 24 hr 543 ± 45 337 ± 35 * 491 ± 26 415 ± 51 n.s.
5 day 587 ± 82 514 ± 40 n.s. 449 ± 65 435 ± 44 n.s.
BAL Chemotaxis (×10
3) 24 hr 52 ± 9 33 ± 3 n.s. 16 ± 1 17 ± 2 n.s.
5 day 41 ± 4 37 ± 4 n.s. 18 ± 2 13 ± 5 n.s.
BAL MPO (U/mL) 24 hr 229 ± 79 104 ± 23 n.s. 128 ± 11 152 ± 57 n.s.
5 day 256 ± 133 301 ± 65 n.s. 142 ± 87 102 ± 19 n.s.
BAL MCP-1 (pg/mL) 24 hr 137 ± 90 42 ± 14 n.s. 188 ± 112 134 ± 48 n.s.
5 day 24 ± 13 101 ± 80 n.s. 187 ± 105 228 ± 59 n.s.
BAL CINC-1 (pg/mL) 24 hr 62 ± 32 32 ± 11 n.s. 66 ± 14 38 ± 12 n.s.
5 day 21 ± 6 30 ± 12 n.s. 36 ± 8 41 ± 7 n.s.
BAL CINC-2 (pg/mL) 24 hr 638 ± 51 554 ± 32 n.s. 267 ± 23 220 ± 28 n.s.
5 day 610 ± 45 552 ± 40 n.s. 266 ± 42 280 ± 18 n.s.
BAL CINC-3 (pg/mL) 24 hr 21 ± 1 21 ± 0.4 n.s. 19 ± 4 19 ± 8 n.s.
5 day 20 ± 0.3 20 ± 0.1 n.s. 18 ± 6 15 ± 4 n.s.
Values are mean ± standard error, where n = 10 Sprague-Dawley, n = 4-5 Copenhagen. *Indicates a value significantly different from vehicle-treated Sham
animals (Bonferroni-adjusted p < 0.05, t-Test). Abbreviations: not significant (n.s.); pleural white blood cell count (WBC); bronchoalveolar lavage fluid (BAL); white
blood cell count (WBC); in vitro neutrophil chemotaxis in response to BAL fluid (Chemotaxis) myeloperoxidase activity (MPO); monocyte chemotactic factor (MCP);
cytokine-induced neutrophil chemotactic factor (CINC).
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3 and 415 ± 51.5 × 10
3 leukocytes in the 24-hour PE
and sham, and 449 ± 65.1 × 10
3 and 435 ± 43.6 × 10
3
leukocytes in the 5-day PE and sham animals. Measured
levels of the chemokines MCP-1, CINC-1, CINC-2, and
CINC-3 were not significantly different in the PE versus
sham animals at either time point.
Discussion
The main findings of this work was that neither Sprague
Dawley nor Copenhagen rat strains demonstrated sus-
tained elevations in right ventricular pressures or a
robust lung inflammatory response after PE induced by
autologous clot in the presence of tranexamic acid.
These findings contrast to the pronounced increases in
right ventricular pressure and lung inflammatory
responses observed after hilar clamp-release models
[12], bead-induced fixed lung ischemia [11], and chemi-
cal-induced pulmonary hypertension [13]. These obser-
vations suggest that persistent vascular obstruction
sufficient to result in sustained pulmonary hypertension
appears necessary to induce the inflammatory response.
Multiple indices of lung inflammation were examined
in the present studies, including BAL leukocyte content,
chemotactic activity, myeloperoxidase activity and che-
mokine content. There was very little indication of sti-
mulation of lung inflammatory processes in any of these
measurements following the infusion of clot material in
either strain of rat. These indications were limited to a
Figure 3 Hemodynamic and clot content measured at the baseline (base), immediately after dosing with clot (Dose) and at the end of
the 24 hour or 5 day experiment in Sprague-Dawley (SD) or Copenhagen (Cop) strains of rats. Animals were treated with vehicle (Sham)
or with pulmonary embolism (PE) injections. Values are mean ± standard error, where n = 10 in the SD and 4-5 in Cop experiments.
*Significantly different from Base (RM ANOVA, t-Test). **Significantly different from Base and from Dose (RM ANOVA, t-Test).
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cant elevation in values for BAL chemotaxis, MPO and
MCP-1 in Sprague-Dawley rats (Table 1). Persistent
obstruction and lung inflammation were not obtained
using single administration of autologous clot material
in either the Sprague-Dawley or Copenhagen rats. A
potential limitation of the present studies is that recur-
rent delivery of clot material was not studied. In con-
trast, our previous studies with fixed pulmonary
vascular obstruction using polystyrene microspheres in
Sprague-Dawley rats produced a robust pulmonary
inflammatory response with a similar peak right ventri-
cular pressure (55 mmHg) [11]. Our previous studies
indicated that the inflammatory response was not due to
direct interactions between endothelial cells and the
polystyrene microspheres, since cultures of vascular
endothelial cells did not produce inflammatory signals
in the presence of the microspheres [11]. Thus, it
appears that pulmonary inflammation results from per-
sistent blockage of the pulmonary circulation. Further-
more, this inflammatory response increased in a dose-
dependent fashion and is most robust when the infused
microsphere burden is sufficient to result in sustained
pulmonary hypertension. These findings further support
our conclusion that persistent vascular obstruction suffi-
cient to induce sustained hypertension is required to
induce a robust inflammatory response.
In our pilot work, we performed necropsies immediately
after clot injection and found that the injected clot mate-
rial does indeed embolize to the pulmonary arteries
(Figure 2). Right ventricular pressures were acutely
increased following clot embolization to approximately 55
mm Hg in Sprague Dawley rats and to approximately 45
mm Hg in the Copenhagen rats. We attempted to enhance
the persistence of embolized clot material by pretreating
the animals with an antifibrinolytic agent, tranexamic acid,
and by adding calcium and thrombin to the tubing to
enhance clot formation. We also “aged” the clot to
enhance clot durability. Despite these measures, the both
rat strains manifested highly active and efficient endogen-
ous fibrinolysis as evidenced by the significant increase in
D-dimer concentrations at 8 hours, the calculated clot
lysis rates, and normalization of right ventricular pressures
by 24 hours. A finding of potential significance, was that
Copenhagen animals had a significantly lower clot lysis
rate than Sprague-Dawley rats at 24 hours (p < 0.001) and
a marginally lower rate at 5 days (p = 0.052). This finding
supports the prior report by Cooley, et al of a prothrom-
botic tendency in the Copenhagen strain [9]. These ani-
mals also required significantly less clot (2.8 mg/100 gm
vs. 22 mg/100 gm) to reach the goal right ventricular pres-
sure. Preliminary attempts to increase the dosing with clot
were fatal in Copenhagen rats. Being an inbred strain, the
Copenhagen rats may be less robust, compared with the
outbred Sprague Dawley rats. Alternatively, the difference
in sensitivity may be due to the lower rate of clot lysis in
the Copenhagen rats. The lower rate of clot lysis was
reflected in the physiology of the Copenhagen animals,
inasmuch as the right ventricular peak systolic pressure
was slower to recover to baseline and only partially recov-
ered from the peak value by the 24 hour period (Figure 3).
Despite these observations, the Copenhagen animals still
did not demonstrate a persistent clot burden sufficient to
result in the sustained pulmonary hypertension that
appears necessary to induce a robust inflammatory
response.
Conclusions
A minimally-invasive autologous clot model of moderate
severity, demonstrated a significantly lower rate of clot
lysis in the Copenhagen strain compared with Sprague-
Dawley animals. Neither strain manifested the persistent
pulmonary hypertension or lung inflammation that is seen
with fixed-occlusion models, suggesting limited utility of
the autologous clot-based modeling for the study of PE in
rats. Persistent pulmonary vascular occlusion sufficient to
result in sustained pulmonary hypertension appears neces-
sary to induce robust lung inflammation after PE.
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Figure 4 Plasma D-dimer concentration measured before (-24
hr), and 8 hr and 24 hr after clot injection in Sprague-Dawley
rats. Grey bars are the sham animals and clear bars are the PE
animals. Values were pooled from the 24 hour and 5 day
experiment. Values are mean ± standard error, n = 20. Star indicates
a value significantly higher than the sham value at the same time
point.
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